BXMX
Income statement / Annual
Last year (2025), Nuveen S&P 500 Buy-Write Income Fund's total revenue was $48.47 M,
an increase of 113.88% from the previous year.
In 2025, Nuveen S&P 500 Buy-Write Income Fund's net income was $208.97 M.
See Nuveen S&P 500 Buy-Write Income Fund,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$48.47 M |
$22.66 M |
$24.65 M |
$153.26 M |
$250.14 M |
$51.69 M |
$208.53 M |
-$78.24 M |
$181.88 M |
$108.31 M |
| Cost of Revenue |
$13.52 M
|
$0.00
|
$12.02 M
|
$12.04 M
|
$12.98 M
|
$11.47 M
|
$11.92 M
|
$12.43 M
|
$12.54 M
|
$11.92 M
|
| Gross Profit |
$34.95 M
|
$22.66 M
|
$242.22 M
|
$141.22 M
|
$237.15 M
|
$40.21 M
|
$196.61 M
|
-$90.67 M
|
$169.34 M
|
$96.39 M
|
| Gross Profit Ratio |
0.72
|
1
|
9.83
|
0.92
|
0.95
|
0.78
|
0.94
|
1.16
|
0.93
|
0.89
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$3.14
|
$0.00
|
-$24.26
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$13.71 M
|
$12.69 M
|
$864.54 K
|
$909.70 K
|
$965.38 K
|
$1.08 M
|
$844.26 K
|
$1.09 M
|
$12.68 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$0.00
|
$13.71 M
|
$12.69 M
|
$864.54 K
|
$909.70 K
|
$965.38 K
|
$1.08 M
|
$844.26 K
|
$1.09 M
|
$12.68 M
|
| Other Expenses |
-$174.06 M
|
$0.00
|
-$11.66 M
|
$29.87 K
|
$21.17 K
|
$11.13 M
|
$14.00 K
|
$10.18 K
|
$1.55 K
|
$0.00
|
| Operating Expenses |
-$174.06 M
|
$13.71 M
|
$1.03 M
|
$894.40 K
|
$930.87 K
|
$12.10 M
|
$1.09 M
|
$854.43 K
|
$1.09 M
|
$83.61 M
|
| Cost And Expenses |
-$160.55 M
|
$13.71 M
|
$12.69 M
|
$337.18 M
|
$930.87 K
|
-$47.53 M
|
$1.09 M
|
$854.43 K
|
$1.09 M
|
-$6.28 M
|
| Interest Income |
$20.85 M
|
$0.00
|
$1.20 M
|
$140.72 K
|
$0.00
|
$28.79 K
|
$356.81 K
|
$282.52 K
|
$81.84 K
|
$0.00
|
| Interest Expense |
$50.85 K
|
$71.36 K
|
$90.93 K
|
$1.09 K
|
$2.55 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
-$8.95 M
|
-$11.96 M
|
-$9.83 M
|
-$4.68 M
|
-$15.16 M
|
-$16.27 M
|
-$15.88 M
|
-$16.21 M
|
-$18.30 M
|
| EBITDA |
$209.02 M |
$0.00 |
$241.28 M |
-$193.75 M |
$244.53 M |
$99.22 M |
$0.00 |
-$79.10 M |
$0.00 |
$114.59 M |
| EBITDA Ratio |
4.31
|
0
|
9.79
|
-1.26
|
0.98
|
1.92
|
0
|
1.01
|
0
|
1.06
|
| Operating Income Ratio |
4.31
|
0.4
|
9.78
|
-1.2
|
1
|
0.29
|
0.99
|
1.01
|
0.99
|
1.06
|
| Total Other Income/Expenses Net |
-$50.55 K
|
$221.91 M
|
$0.00
|
-$1.09 K
|
-$2.55 K
|
$84.06 M
|
$0.00
|
$12.43 M
|
$164.58 M
|
$0.00
|
| Income Before Tax |
$208.97 M
|
$230.86 M
|
$241.19 M
|
-$183.92 M
|
$249.20 M
|
$99.22 M
|
$207.44 M
|
-$79.10 M
|
$180.79 M
|
$114.59 M
|
| Income Before Tax Ratio |
4.31
|
10.19
|
9.78
|
-1.2
|
1
|
1.92
|
0.99
|
1.01
|
0.99
|
1.06
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$161.14 K
|
$16.21 M
|
$0.00
|
| Net Income |
$208.97 M
|
$230.86 M
|
$241.19 M
|
-$183.92 M
|
$249.20 M
|
$99.22 M
|
$207.44 M
|
-$79.10 M
|
$180.79 M
|
$114.59 M
|
| Net Income Ratio |
4.31
|
10.19
|
9.78
|
-1.2
|
1
|
1.92
|
0.99
|
1.01
|
0.99
|
1.06
|
| EPS |
2.01 |
2.22 |
2.32 |
-1.77 |
2.39 |
0.95 |
1.99 |
-0.76 |
1.74 |
1.11 |
| EPS Diluted |
2.01 |
2.22 |
2.32 |
-1.77 |
2.39 |
0.95 |
1.99 |
-0.76 |
1.74 |
1.11 |
| Weighted Average Shares Out |
$104.17 M
|
$104.17 M
|
$104.17 M
|
$104.09 M
|
$104.09 M
|
$104.09 M
|
$104.02 M
|
$103.72 M
|
$103.55 M
|
$103.55 M
|
| Weighted Average Shares Out Diluted |
$104.17 M
|
$104.17 M
|
$104.17 M
|
$104.09 M
|
$104.09 M
|
$104.09 M
|
$104.02 M
|
$104.07 M
|
$103.90 M
|
$103.55 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
